Background: Objective data on chemosensitive disorders during COVID-19 are lacking in the Literature.
Methods: Multicenter cohort study that involved four Italian hospitals. Three hundred and forty-five COVID-19 patients underwent objective chemosensitive evaluation.
Results: Chemosensitive disorders self-reported by 256 patients (74.2%) but the 30.1% of the 89 patients who did not report dysfunctions proved objectively hyposmic. Twenty-five percentage of patients were seen serious long-lasting complaints. All asymptomatic patients had a slight lowering of the olfactory threshold. No significant correlations were found between the presence and severity of chemosensitive disorders and the severity of the clinical course. On the contrary, there is a significant correlation between the duration of the olfactory and gustatory symptoms and the development of severe COVID-19.
Conclusions: Patients under-report the frequency of chemosensitive disorders. Contrary to recent reports, such objective testing refutes the proposal that the presence of olfactory and gustatory dysfunction may predict a milder course, but instead suggests that those with more severe disease neglect such symptoms in the setting of severe respiratory disease.
Keywords: COVID-19; ageusia; anosmia; smell; taste.
© 2020 Wiley Periodicals, Inc.
Olfactory and gustatory dysfunctions as a clinical presentation of mild-to-moderate forms of the coronavirus disease (COVID-19): a multicenter European study.Eur Arch Otorhinolaryngol. 2020 Apr 6:1-11. doi: 10.1007/s00405-020-05965-1. Online ahead of print. Eur Arch Otorhinolaryngol. 2020. PMID: 32253535 Free PMC article.
Objective evaluation of anosmia and ageusia in COVID-19 patients: Single-center experience on 72 cases.Head Neck. 2020 Jun;42(6):1252-1258. doi: 10.1002/hed.26204. Epub 2020 Apr 29. Head Neck. 2020. PMID: 32342566
Validation of a self-administered olfactory and gustatory test for the remotely evaluation of COVID-19 patients in home quarantine.Head Neck. 2020 May 1. doi: 10.1002/hed.26228. Online ahead of print. Head Neck. 2020. PMID: 32357379
Taste and smell as chemosensory dysfunctions in COVID-19 infection.Am J Dent. 2020 Jun;33(3):135-137. Am J Dent. 2020. PMID: 32470238 Review.
Neuroanatomy, Nucleus Gustatory.2020 Apr 2. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2020 Jan–. StatPearls. 2020 Jan–. PMID: 32119409 Free Books & Documents. Review.
- Rothan HA, Byrareddy SN. The epidemiology and pathogenesis of coronavirus disease (COVID-19) outbreak. J Autoimmun. 2020;109:102433. https://doi.org/10.1016/j.jaut.2020.102433.
- Day M. Covid-19: four fifths of cases are asymptomatic, China figures indicate. BMJ. 2020. https://doi.org/10.1136/bmj.m1375.
- Mao L, Wang M, Chen S, et al. Neurological manifestations of hospitalized patients with COVID-19 in Wuhan, China: a retrospective case series study. JAMA Neurol. https://doi.org/10.1001/jamaneurol.2020.1127.
- Vaira LA, Salzano G, Deiana G, De Riu G. Ageusia and anosmia: common findings in COVID-19 patients. Laryngoscope. 2020. https://doi.org/10.1002/lary.28692.
- Xydakis MS, Dehgani-Mobaraki P, Holbrook EH, et al. Smell and taste dysfunction in patients with COVID-19. Lancet Infect Dis. 2020. https://doi.org/10.1016/S1473-3099(20)30293-0.